Literature DB >> 19346101

Primary Ovarian Insufficiency: X chromosome defects and autoimmunity.

Luca Persani1, Raffaella Rossetti, Chiara Cacciatore, Marco Bonomi.   

Abstract

Premature ovarian failure (POF) is a primary ovarian defect characterized by absent menarche or premature depletion of ovarian follicles before the age of 40 years. However, in several instances the distinction between definitive or intermittent POF may be difficult on clinical bases, therefore the more appropriate term Primary Ovarian Insufficiency (POI) has been recently proposed and will be used in this review. POI is a heterogeneous disorder affecting approximately 1% of women <40 years. The most severe forms present with absent pubertal development and primary amenorrhea, whereas forms with post-pubertal onset are characterized by disappearance of menstrual cycles (secondary amenorrhea) associated with a defective folliculogenesis. POI is generally characterized by low levels of gonadal hormones (estrogens and inhibins) and high levels of gonadotropins (LH and FSH) (hypergonadotropic amenorrhea). Heterogeneity of POI is reflected by the variety of possible causes, including autoimmunity, toxics, drugs, as well as genetic defects. Several data indicate that POI has a strong genetic component. In this manuscript we discuss the X chromosome abnormalities that are associated with POI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346101     DOI: 10.1016/j.jaut.2009.03.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  31 in total

1.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 2.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 3.  Update on primary biliary cirrhosis.

Authors:  Pietro Invernizzi; Carlo Selmi; M Eric Gershwin
Journal:  Dig Liver Dis       Date:  2010-03-31       Impact factor: 4.088

4.  Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF).

Authors:  C R Quilter; A C Karcanias; M R Bagga; S Duncan; A Murray; G S Conway; C A Sargent; N A Affara
Journal:  Hum Reprod       Date:  2010-06-22       Impact factor: 6.918

5.  Immune-mediated bile duct injury: The case of primary biliary cirrhosis.

Authors:  Carlo Selmi; Andrea Affronti; Laura Ferrari; Pietro Invernizzi
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

6.  Genomic variants associated with primary biliary cirrhosis.

Authors:  Carlo Selmi; Natalie J Torok; Andrea Affronti; M Eric Gershwin
Journal:  Genome Med       Date:  2010-01-26       Impact factor: 11.117

7.  Gender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent children.

Authors:  Georges Ja Casimir; Fabienne Heldenbergh; Laurence Hanssens; Sandra Mulier; Claudine Heinrichs; Nicolas Lefevre; Julie Désir; Francis Corazza; Jean Duchateau
Journal:  J Inflamm (Lond)       Date:  2010-06-02       Impact factor: 4.981

Review 8.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 9.  Epigenetics in rheumatoid arthritis.

Authors:  Michelle Trenkmann; Matthias Brock; Caroline Ospelt; Steffen Gay
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 10.  Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials.

Authors:  Sha Zhao; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.